{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:28:32Z","timestamp":1773293312801,"version":"3.50.1"},"reference-count":36,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:p>OBJECTIVES. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress.<\/jats:p>\n               <jats:p>PATIENTS AND METHODS. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of &amp;lt;1250 g birth weight who received inhaled nitric oxide (20 ppm, weaned to 2 ppm) or placebo gas for 24 days. Plasma was assayed for total protein and for 3-nitrotyrosine and carbonylation by using immunoassays.<\/jats:p>\n               <jats:p>RESULTS. The demographic characteristics and primary outcome for the infants were representative of the entire group of infants who were in the Nitric Oxide Chronic Lung Disease Trial. For all infants at baseline, before receiving study gas, the concentration of total protein was inversely correlated with the respiratory severity score, and plasma carbonyl was positively correlated with severity score, supporting an association between oxidative stress and severity of lung disease. Infants who survived without bronchopulmonary dysplasia had 30% lower protein carbonylation concentrations at study entry than those who had an adverse outcome. At each of 3 time points (1\u201310 days) during exposure to study gas, there were no significant differences between control and treated infants for concentrations of plasma protein, 3-nitrotyrosine, and carbonylation.<\/jats:p>\n               <jats:p>CONCLUSIONS. Inhaled nitric oxide treatment for premature infants who are at risk for bronchopulmonary dysplasia does not alter plasma biomarkers of oxidative stress, which supports the safety of this therapy.<\/jats:p>","DOI":"10.1542\/peds.2007-2479","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T14:48:09Z","timestamp":1204296489000},"page":"555-561","source":"Crossref","is-referenced-by-count":52,"title":["Plasma Biomarkers of Oxidative Stress: Relationship to Lung Disease and Inhaled Nitric Oxide Therapy in Premature Infants"],"prefix":"10.1542","volume":"121","author":[{"given":"Philip L.","family":"Ballard","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Truog","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Mercy Hospitals and Clinics\/University of Missouri-Kansas City School of Medicine, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Merrill","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Biostatistics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Gow","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Rutgers University, New Brunswick, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Posencheg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Biostatistics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio G.","family":"Golombek","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, New York Medical College\/Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance A.","family":"Parton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, New York Medical College\/Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianqun","family":"Luan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Biostatistics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avital","family":"Cnaan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Biostatistics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta A.","family":"Ballard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"2021120905472139100_R1","doi-asserted-by":"crossref","unstructured":"Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med.2003;349(22):2099\u20132107","DOI":"10.1056\/NEJMoa031154"},{"key":"2021120905472139100_R2","doi-asserted-by":"crossref","unstructured":"Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for preterm infants with severe respiratory failure. N Engl J Med.2005;353(1):13\u201322","DOI":"10.1056\/NEJMoa043927"},{"key":"2021120905472139100_R3","doi-asserted-by":"crossref","unstructured":"Field D, Elbourne D, Truesdale A, et al. Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339). Pediatrics.2005;115(4):926\u2013936","DOI":"10.1542\/peds.2004-1209"},{"key":"2021120905472139100_R4","doi-asserted-by":"crossref","unstructured":"Ballard RA, Truog WE, Cnaan A, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med.2006;355(4):343\u2013353","DOI":"10.1056\/NEJMoa061088"},{"key":"2021120905472139100_R5","doi-asserted-by":"crossref","unstructured":"Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med.2006;355(4):354\u2013364","DOI":"10.1056\/NEJMoa060442"},{"key":"2021120905472139100_R6","doi-asserted-by":"crossref","unstructured":"Ballard RA. Inhaled nitric oxide in preterm infants: correction. N Engl J Med.2007;357(14):1444\u20131445","DOI":"10.1056\/NEJMc076350"},{"key":"2021120905472139100_R7","doi-asserted-by":"crossref","unstructured":"Saugstad OD. Bronchopulmonary dysplasia oxidative stress and antioxidants. Semin Neonatol.2003;8(1):39\u201349","DOI":"10.1016\/S1084-2756(02)00194-X"},{"key":"2021120905472139100_R8","doi-asserted-by":"crossref","unstructured":"Stadtman ER. Protein oxidation and aging. Science.1992;257(5074):1220\u20131224","DOI":"10.1126\/science.1355616"},{"key":"2021120905472139100_R9","doi-asserted-by":"crossref","unstructured":"Ellis EM. Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol Ther.2007;115(1):13\u201324","DOI":"10.1016\/j.pharmthera.2007.03.015"},{"key":"2021120905472139100_R10","doi-asserted-by":"crossref","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev.2007;87(1):315\u2013424","DOI":"10.1152\/physrev.00029.2006"},{"key":"2021120905472139100_R11","doi-asserted-by":"crossref","unstructured":"Brennan ML, Wu W, Fu X, et al. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem.2002;277(20):17415\u201317427","DOI":"10.1074\/jbc.M112400200"},{"key":"2021120905472139100_R12","doi-asserted-by":"crossref","unstructured":"Robbins CG, Davis JM, Merritt TA, et al. Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am J Physiol.1995;269(4 pt 1):L545\u2013L550","DOI":"10.1152\/ajplung.1995.269.4.L545"},{"key":"2021120905472139100_R13","doi-asserted-by":"crossref","unstructured":"Bhabra MS. Modulation of lung reperfusion injury by nitric oxide: impact of inspired oxygen fraction. Transplantation.1999;68(9):1238\u20131243","DOI":"10.1097\/00007890-199911150-00005"},{"key":"2021120905472139100_R14","doi-asserted-by":"crossref","unstructured":"Ekekezie II, Thibeault DW, Zwick DL, et al. Independent and combined effects of prolonged inhaled nitric oxide and oxygen on lung inflammation in newborn piglets. Biol Neonate.2000;77(1):37\u201344","DOI":"10.1159\/000014193"},{"key":"2021120905472139100_R15","doi-asserted-by":"crossref","unstructured":"Hallman M, Waffarn F, Bry K, et al. Surfactant dysfunction after inhalation of nitric oxide. J Appl Physiol.1996;80(6):2026\u20132034","DOI":"10.1152\/jappl.1996.80.6.2026"},{"key":"2021120905472139100_R16","doi-asserted-by":"crossref","unstructured":"Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method [published correction appears in Free Radic Biol Med. 1998;24(7\u20138):1352]. Free Radic Biol Med.1997;23(3):361\u2013366","DOI":"10.1016\/S0891-5849(97)00104-4"},{"key":"2021120905472139100_R17","doi-asserted-by":"crossref","unstructured":"Winterbourn CC, Chan T, Buss IH, Inder TE, Mogridge N, Darlow BA. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effects of selenium supplementation. Pediatr Res.2000;48(1):84\u201390","DOI":"10.1203\/00006450-200007000-00015"},{"key":"2021120905472139100_R18","doi-asserted-by":"crossref","unstructured":"Varsila E, Pesonen E, Andersson S. Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr.1995;84(11):1296\u20131299","DOI":"10.1111\/j.1651-2227.1995.tb13552.x"},{"key":"2021120905472139100_R19","doi-asserted-by":"crossref","unstructured":"Inder TE, Darlow BA, Sluis KB, et al. The correlation of elevated levels of an index of lipid peroxidation (MDA-TBA) with adverse outcome in the very low birthweight infant. Acta Paediatr.1996;85(9):1116\u20131122","DOI":"10.1111\/j.1651-2227.1996.tb14228.x"},{"key":"2021120905472139100_R20","doi-asserted-by":"crossref","unstructured":"Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics.1998;101(5):870\u2013874","DOI":"10.1542\/peds.101.5.870"},{"key":"2021120905472139100_R21","doi-asserted-by":"crossref","unstructured":"Buonocore G, Zani S, Perrone S, Caciotti B, Bracci R. Intraerythrocyte nonprotein-bound iron and plasma malondialdehyde in the hypoxic newborn. Free Radic Biol Med.1998;25(7):766\u2013770","DOI":"10.1016\/S0891-5849(98)00126-9"},{"key":"2021120905472139100_R22","doi-asserted-by":"crossref","unstructured":"Hallman M, Chundu V, Barsotti M, Bry K. Transferrin modifies surfacant responsiveness in acute respiratory failure: role of iron-free transferrin as an antioxidant. Pediatr Pulmonol.1996;22(1):14\u201322","DOI":"10.1002\/(SICI)1099-0496(199607)22:1<14::AID-PPUL3>3.0.CO;2-K"},{"key":"2021120905472139100_R23","doi-asserted-by":"crossref","unstructured":"Davis JM, Parad RB, Michele T, et al. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics.2003;111(3):469\u2013476","DOI":"10.1542\/peds.111.3.469"},{"key":"2021120905472139100_R24","doi-asserted-by":"crossref","unstructured":"Gow A, Duran D, Thom SR, Ischiropoulos H. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys.1996;333(1):42\u201348","DOI":"10.1006\/abbi.1996.0362"},{"key":"2021120905472139100_R25","doi-asserted-by":"crossref","unstructured":"Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med.1995;51(4):1250\u20131254","DOI":"10.1164\/ajrccm.151.4.7697261"},{"key":"2021120905472139100_R26","doi-asserted-by":"crossref","unstructured":"Shishehbor MH, Aviles RJ, Brennan ML, et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA.2003;289(13):1675\u20131680","DOI":"10.1001\/jama.289.13.1675"},{"key":"2021120905472139100_R27","doi-asserted-by":"crossref","unstructured":"Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med.2003;349(17):1595\u20131604","DOI":"10.1056\/NEJMoa035003"},{"key":"2021120905472139100_R28","doi-asserted-by":"crossref","unstructured":"Munson DA, Grubb PH, Kerecman JD, et al. Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease. Am J Respir Cell Mol Biol.2005;33(6):582\u2013588","DOI":"10.1165\/rcmb.2005-0182OC"},{"key":"2021120905472139100_R29","doi-asserted-by":"crossref","unstructured":"Lorch SA, Banks BA, Christie J, et al. Plasma 3-nitrotyrosine and outcome in neonates with severe bronchopulmonary dysplasia after inhaled nitric oxide. Free Radic Biol Med.2003;34(9):1146\u20131152","DOI":"10.1016\/S0891-5849(03)00063-7"},{"key":"2021120905472139100_R30","doi-asserted-by":"crossref","unstructured":"Bland RD. Cord-blood total protein level as a screening aid for the idiopathic respiratory-distress syndrome. N Engl J Med.1972;287(1):9\u201313","DOI":"10.1056\/NEJM197207062870103"},{"key":"2021120905472139100_R31","doi-asserted-by":"crossref","unstructured":"Moison RM, Haasnoot AA, Van Zoeren-Grobben D, Berger HM. Plasma proteins in acute and chronic lung disease of the newborn. Free Radic Biol Med.1998;25(3):321\u2013328","DOI":"10.1016\/S0891-5849(98)00070-7"},{"key":"2021120905472139100_R32","doi-asserted-by":"crossref","unstructured":"Orhan H, Vermeulen NP, Tump C, Zappey H, Meerman JH. Simultaneous determination of tyrosine, phenylalanine and deoxyguanosine oxidation products by liquid chromatography-tandem mass spectrometry as non-invasive biomarkers for oxidative damage. J Chromatogr B Analyt Technol Biomed Life Sci.2004;799(2):245\u2013254","DOI":"10.1016\/j.jchromb.2003.10.056"},{"key":"2021120905472139100_R33","doi-asserted-by":"crossref","unstructured":"Truog WE, Ballard PL, Norberg M, et al. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide. Pediatrics.2007;119(4):670\u2013678","DOI":"10.1542\/peds.2006-2683"},{"key":"2021120905472139100_R34","doi-asserted-by":"crossref","unstructured":"McCurnin DC, Pierce RA, Chang LY, et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol.2005;288(3):L450\u2013L459","DOI":"10.1152\/ajplung.00347.2004"},{"key":"2021120905472139100_R35","doi-asserted-by":"crossref","unstructured":"Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med.2005;172(7):899\u2013906","DOI":"10.1164\/rccm.200503-384OC"},{"key":"2021120905472139100_R36","doi-asserted-by":"crossref","unstructured":"Balasubramaniam V, Maxey AM, Morgan DB, Markham NE, Abman SH. Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol.2006;291(1):L119\u2013L127","DOI":"10.1152\/ajplung.00395.2005"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/3\/555\/1124082\/zpe00308000555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/3\/555\/1124082\/zpe00308000555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T23:34:45Z","timestamp":1639092885000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/3\/555\/72789\/Plasma-Biomarkers-of-Oxidative-Stress-Relationship"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,3,1]]},"published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-2479","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}